Cancer Chemotherapy: Cancer Chemotherapy and Biological Response Modifiers

Drugs Section. Antimetabolites (J.L. Grem et al.). Bleomycin (S. Lazo). Mitomycins (Verweij et al.). Taxanes and other microtubule stabilizing agents (D.L. Sackett, T. Fojo). DNA topoisomerase I poisons (C.H. Takimoto et al.). DNA topoisomerase II poisons(G. Capranico et al.). Cisplatin (E. Reed). Multidrug resistance (E. Schneider et al.). New anticancer agents (C. Britten et al.). Biological Response Modifiers Section. Monoclonal antibodies, cytokines and fusion proteins in the treatment of malignant disease (J.A. Hank et al.). Biological response modifiers (J.W. Clark). Adoptive immunotherapy (B.D. Curti). Hematopoietic growth factors in cancer chemotherapy (J. Crawford et al.). Tumors Section. Leukemias and plasma cell myeloma (P.H. Wiernik). Non-Hodgkin's lymphomas (N.L. Bartlett, N.D. Wagner). Head and neck cancer (S.G. Taylor). Lung cancer (H.H. Hansen, M. Rorth). Upper gastrointestinal tumors (M. Ogawa, T.Taguchi). Cancers of the large bowel and hepato-biliary tract (V.M. Aviles, D.J. Vaughn). Endocrine tumors (S.W.J. Lamberts). Genitourinary malignancies (M.R. Smith, P. Kantoff). Gynecological cancers (M.P. Boente et al.). Breast cancer (A. Budzar, G.N. Hortobagyi). Melanoma (F.G. Haluska, P.S. Multani). Soft tissue and bone sarcomas (A. Santoro, H.S. Parra). Brain Tumors (L.S. Ashby et al.). Biology and therapy of pediatric malignant solid tumors (N. Marina). Supportive care (M. Markman).